A SOLUBILITY-ENHANCED PHARMACEUTICAL FORMULATION COMPRISING SILODOSIN

摘要

The present invention relates to a pharmaceutical formulation and a producing method thereof, comprising a solid dispersion formed by making silicon dioxide adsorb silodosin or a pharmaceutically acceptable salt thereof. The silodosin or the pharmaceutically acceptable salt thereof and povidone are mixed at the ratio of 1 : 0.5 to 2 parts by weight, and elution properties of silodosin can be improved.